107 related articles for article (PubMed ID: 229712)
21. Effect of ACTH administration on urinary kallikrein excretion in man.
Whitworth JA; van Leeuwen BH; Hannah MC; Scoggins BA; Thatcher R
Clin Exp Pharmacol Physiol; 1984; 11(1):87-90. PubMed ID: 6325055
[TBL] [Abstract][Full Text] [Related]
22. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
Ohman KP; Karlberg BE; Nilsson OR; Wettre S
Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
[TBL] [Abstract][Full Text] [Related]
23. Effect of sodium depletion on active renin, inactive renin and prekallikrein in plasma and urinary kallikrein excretion in glomerulonephritic patients.
Tsai TJ; Chen WY; Yen TS
J Formos Med Assoc; 1990 May; 89(5):341-5. PubMed ID: 1977841
[TBL] [Abstract][Full Text] [Related]
24. Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids.
Margolius HS; Horwitz D; Pisano JJ; Keiser HR
Circ Res; 1974 Dec; 35(6):820-5. PubMed ID: 4430079
[No Abstract] [Full Text] [Related]
25. Renin-angiotensin and kallikrein-kinin systems in sodium homeostasis and hypertension in rats.
Johnston CI; Matthews PG; Dax E
Clin Sci Mol Med Suppl; 1976 Dec; 3():283s-286s. PubMed ID: 1071628
[TBL] [Abstract][Full Text] [Related]
26. Role of renal kallikrein in the derangement of sodium and water excretion in cirrhotic patients.
Hattori K; Hasumura Y; Takeuchi J
Scand J Gastroenterol; 1984 Sep; 19(6):844-8. PubMed ID: 6393317
[TBL] [Abstract][Full Text] [Related]
27. Aldosterone and other mineralocorticoids in Bartter's syndrome.
Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
[TBL] [Abstract][Full Text] [Related]
28. Renal vasoactive hormones in scleroderma (progressive systemic sclerosis).
Oliver JA; Vinci JM; Bowden RE; Weinberger AB; Baer L; Keiser HR; Cannon PJ
Nephron; 1981; 29(3-4):110-6. PubMed ID: 7035981
[TBL] [Abstract][Full Text] [Related]
29. Effect of low normal and high normal sodium intake on hormonal and metabolic responses to ACTH, angiotensin II and an acute salt load in normal subjects.
Schiffrin EL; Gutkowska J; Julesz J; Thibault G; Genest J
Clin Invest Med; 1984; 7(3):149-55. PubMed ID: 6097382
[TBL] [Abstract][Full Text] [Related]
30. Urinary kallikrein excretion in glomerulonephritis and nephrotic syndrome.
Cumming AD; Robson JS
Nephron; 1985; 39(3):206-10. PubMed ID: 3844632
[TBL] [Abstract][Full Text] [Related]
31. Urinary kallikrein and plasma renin activity in normal human pregnancy.
Valdés G; Espinoza P; Moore R; Croxatto HR
Hypertension; 1981; 3(6 Pt 2):II-55-8. PubMed ID: 7028622
[TBL] [Abstract][Full Text] [Related]
32. The role of renal kallikrein-kinin system in the renal escape from the sodium retaining effect of aldosterone in primary hyperaldosteronism.
Haruyama T; Abe K; Sato M; Hiwatari M; Sato K; Kasai Y; Goto T; Tajima J; Itoh S; Yoshinaga K
Adv Exp Med Biol; 1983; 156 (Pt B)():985-94. PubMed ID: 6552870
[No Abstract] [Full Text] [Related]
33. The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance.
Sellars L; Shore AC; Mott V; Wilkinson R
Q J Med; 1985 Aug; 56(220):485-96. PubMed ID: 3901077
[TBL] [Abstract][Full Text] [Related]
34. On the pathogenesis of Bartter's syndrome: report of studies in a patient with this disorder.
Norby L; Mark AL; Kaloyanides GJ
Clin Nephrol; 1976 Sep; 6(3):404-13. PubMed ID: 991467
[TBL] [Abstract][Full Text] [Related]
35. Urinary kallikrein excretion in normal man. Relationships to sodium intake and sodium-retaining steroids.
Margolius HS; Horwitz D; Geller RG; Alexander RW; Gill JR; Pisano JJ; Keiser HR
Circ Res; 1974 Dec; 35(6):812-9. PubMed ID: 4430078
[No Abstract] [Full Text] [Related]
36. Responses of active and inactive plasma renin and changes in urinary kallikrein and plasma prekallikrein to various conditions in normal subjects.
Nakamaru M; Ogihara T; Higaki J; Hata T; Ohde H; Naka T; Masuo K; Gotoh S; Kumahara Y; Murakami K
J Clin Endocrinol Metab; 1982 Apr; 54(4):682-8. PubMed ID: 7037811
[TBL] [Abstract][Full Text] [Related]
37. [Variations in renin and aldosterone activity in a typical case of Barter syndrome. Influence of anti-aldosterones and sodium intake].
Zech P; Pozet N; Sassard J; Leitienne P; Blanc N; Colon S; Berthoux F; Touraine JL; Traeger J
J Urol Nephrol (Paris); 1974 Sep; 80(9):760-5. PubMed ID: 4463254
[No Abstract] [Full Text] [Related]
38. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.
Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K
J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807
[TBL] [Abstract][Full Text] [Related]
39. Acute effect of potassium canrenoate administration on renin-angiotensin, kallikrein-kinin and prostaglandin systems.
Lahera V; Cachofeiro V; Duran F; Cañizo FJ; Rodriguez FJ; Tresguerres JA
Gen Pharmacol; 1988; 19(6):835-9. PubMed ID: 3068096
[TBL] [Abstract][Full Text] [Related]
40. Loss of sodium modulation of plasma kinins in human hypertension.
Murphey LJ; Eccles WK; Williams GH; Brown NJ
J Pharmacol Exp Ther; 2004 Mar; 308(3):1046-52. PubMed ID: 14718610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
